Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Online Hemodiafiltration With Endogenous Reinfusion in Treatment of Systemic Lupus Erythematosus Activity Resistant to Conventional Therapy

NCT04108611 is registered in ClinicalTrials.gov with Dr. Mohamed Ahmed El ghiriani as lead sponsor.

NCT NCT04108611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04108611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Online Hemodiafiltration With Endogenous Reinfusion in Treatment of Systemic Lupus Erythematosus Activity Resistant to Conventional Therapy
Lead sponsor
Dr. Mohamed Ahmed El ghiriani
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2019
Completion date
September 25, 2019
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus